TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
88.24
+19.26 (27.92%)
At close: Nov 6, 2026, 4:00 PM EST
88.00
-0.24 (-0.27%)
After-hours: Nov 6, 2026, 7:58 PM EST
TransMedics Group Revenue
TransMedics Group had revenue of $203.01M in the quarter ending September 30, 2026, with 41.15% growth. This brings the company's total for the last twelve months to $727.65M, up 28.48% year-over-year. In the year 2025, TransMedics Group had annual revenue of $605.49M with 37.13% growth. That makes TransMedics Group the 9,208th largest company in the world by revenue and 2,042nd in the United States.
Revenue (ttm)
$727.65M
Revenue Growth
+28.48%
P/S Ratio
4.21
Revenue / Employee
$810,301
Employees
898
Market Cap
3.06B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full TransMedics Group breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 605.49M | 163.95M | 37.13% |
| Dec 31, 2024 | 441.54M | 199.92M | 82.74% |
| Dec 31, 2023 | 241.62M | 148.16M | 158.53% |
| Dec 31, 2022 | 93.46M | 63.20M | 208.83% |
| Dec 31, 2021 | 30.26M | 4.62M | 18.03% |
| Dec 31, 2020 | 25.64M | 2.04M | 8.62% |
| Dec 28, 2019 | 23.60M | 10.59M | 81.33% |
| Dec 31, 2018 | 13.02M | 5.33M | 69.38% |
| Dec 30, 2017 | 7.69M | -5.33M | -40.96% |
| Dec 31, 2016 | 13.02M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Integer Holdings | 1.83B |
| LivaNova | 1.51B |
| Haemonetics | 1.38B |
| Neogen | 884.00M |
| Inspire Medical Systems | 880.94M |
| iRhythm Holdings | 854.04M |
| UFP Technologies | 649.52M |
| Axogen | 266.93M |
TMDX News
- 18 hours ago - TransMedics price target raised to $120 from $95 at Canaccord - TheFly
- 18 hours ago - TransMedics price target raised to $85 from $73 at JPMorgan - TheFly
- 18 hours ago - TransMedics price target raised to $70 from $65 at Stifel - TheFly
- 19 hours ago - TransMedics price target raised to $117 from $110 at Baird - TheFly
- 1 day ago - TransMedics Group Earnings Call Transcript: Q3 2026 - Transcripts
- 1 day ago - TransMedics Group Earnings release: Q3 2026 - Filings
- 1 day ago - TransMedics Group Quarterly report: Q3 2026 - Filings
- 1 day ago - TransMedics Group Slides: Q3 2026 - Filings